Minimally Invasive Therapies Group
E46438
Minimally Invasive Therapies Group is a Medtronic business unit focused on developing and providing technologies and solutions for minimally invasive surgical and interventional procedures.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Minimally Invasive Therapies Group canonical | 2 |
How this entity was disambiguated
This entity first appeared as the object of triple T365501 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
Target entity: Minimally Invasive Therapies Group Context triple: [Medtronic, hasDivision, Minimally Invasive Therapies Group]
-
A.
Committee for Advanced Therapies
The Committee for Advanced Therapies is a scientific body within the European Medicines Agency responsible for evaluating and providing expert opinions on advanced therapy medicinal products such as gene, cell, and tissue-engineered therapies.
-
B.
Center for Cellular and Molecular Therapeutics
The Center for Cellular and Molecular Therapeutics is a research institute specializing in developing gene and cell-based therapies for pediatric and genetic diseases.
-
C.
National Institute of Biomedical Imaging and Bioengineering
The National Institute of Biomedical Imaging and Bioengineering is a U.S. federal research institute that advances the development and application of biomedical imaging and bioengineering technologies to improve health.
-
D.
Division of Cancer Treatment and Diagnosis
The Division of Cancer Treatment and Diagnosis is a branch of the National Cancer Institute that supports the development, evaluation, and clinical testing of new cancer therapies and diagnostic tools.
-
E.
Center for Health and Biosciences
The Center for Health and Biosciences is a research and policy institute focused on health care, biomedical innovation, and related public policy issues.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Target entity: Minimally Invasive Therapies Group Target entity description: Minimally Invasive Therapies Group is a Medtronic business unit focused on developing and providing technologies and solutions for minimally invasive surgical and interventional procedures.
-
A.
Committee for Advanced Therapies
The Committee for Advanced Therapies is a scientific body within the European Medicines Agency responsible for evaluating and providing expert opinions on advanced therapy medicinal products such as gene, cell, and tissue-engineered therapies.
-
B.
Center for Cellular and Molecular Therapeutics
The Center for Cellular and Molecular Therapeutics is a research institute specializing in developing gene and cell-based therapies for pediatric and genetic diseases.
-
C.
National Institute of Biomedical Imaging and Bioengineering
The National Institute of Biomedical Imaging and Bioengineering is a U.S. federal research institute that advances the development and application of biomedical imaging and bioengineering technologies to improve health.
-
D.
Division of Cancer Treatment and Diagnosis
The Division of Cancer Treatment and Diagnosis is a branch of the National Cancer Institute that supports the development, evaluation, and clinical testing of new cancer therapies and diagnostic tools.
-
E.
Center for Health and Biosciences
The Center for Health and Biosciences is a research and policy institute focused on health care, biomedical innovation, and related public policy issues.
- F. None of above. chosen
Statements (25)
| Predicate | Object |
|---|---|
| instanceOf |
Medtronic business unit
ⓘ
business unit ⓘ |
| areaServed | global ⓘ |
| associatedWith |
interventional innovation
ⓘ
surgical innovation ⓘ |
| belongsTo | Medtronic portfolio ⓘ |
| develops |
solutions for interventional procedures
ⓘ
technologies for minimally invasive surgery ⓘ |
| focus |
interventional procedures
ⓘ
minimally invasive surgical procedures ⓘ minimally invasive therapies ⓘ |
| goal |
advance minimally invasive treatment options
ⓘ
support clinicians in performing less invasive procedures ⓘ |
| industry |
healthcare technology
ⓘ
medical devices ⓘ |
| offers |
interventional technologies
ⓘ
medical devices for minimally invasive procedures ⓘ surgical technologies ⓘ |
| parentOrganization | Medtronic ⓘ |
| partOf | Medtronic operating segments ⓘ |
| productType |
interventional devices
ⓘ
medical technology platforms ⓘ surgical instruments ⓘ |
| purpose |
improve patient outcomes through minimally invasive care
ⓘ
reduce invasiveness of surgical procedures ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Subject: Minimally Invasive Therapies Group Description of subject: Minimally Invasive Therapies Group is a Medtronic business unit focused on developing and providing technologies and solutions for minimally invasive surgical and interventional procedures.
Referenced by (2)
Full triples — surface form annotated when it differs from this entity's canonical label.